Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 1 Meningeal Carcinomatosis 1 Lymphoproliferative Disorders 1 Lymphomatoid Granulomatosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Epstein-Barr Virus Infections 1 Brain Neoplasms 1

Interventions

ruxolitinib 12 fludarabine phosphate 5 Whole-Body Irradiation 5 Cyclophosphamide 5 Tacrolimus 4 Peripheral Blood Stem Cell Transplantation 4 Mycophenolic Acid 4 Hydroxyurea 4 bomedemstat 3 Stem Cell Transplantation 3 Specimen Handling 3 Busulfan 3 Biopsy 3 Aspirin 3 fludarabine 2 Phlebotomy 2 Methotrexate 2 Melphalan 2 Injections 2 Azacitidine 2 venetoclax 1 veliparib 1 umbralisib 1 piperine 1 pevonedistat 1 methanesulfonic acid 1 itacitinib 1 iadademstat 1 givinostat hydrochloride 1 givinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Polycythemia Vera × Interferons × 1 year × Clear all

NCT04116502 2026-04-28

MITHRIDATE

University of Birmingham

Phase 3 Recruiting

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡